These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 29696374)
21. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia. Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150 [TBL] [Abstract][Full Text] [Related]
22. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Langer C; Radmacher MD; Ruppert AS; Whitman SP; Paschka P; Mrózek K; Baldus CD; Vukosavljevic T; Liu CG; Ross ME; Powell BL; de la Chapelle A; Kolitz JE; Larson RA; Marcucci G; Bloomfield CD; Blood; 2008 Jun; 111(11):5371-9. PubMed ID: 18378853 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of combined BAALC and MN1 gene expression level in acute myeloid leukemia with normal karyotype. Marjanovic I; Karan-Djurasevic T; Kostic T; Virijevic M; Vukovic NS; Pavlovic S; Tosic N Int J Lab Hematol; 2021 Jun; 43(3):433-440. PubMed ID: 33242229 [TBL] [Abstract][Full Text] [Related]
24. Relation of BAALC and ERG Gene Expression with Overall Survival in Acute Myeloid Leukemia Cases. Rashed RA; Kadry DY; El Taweel M; Abd El Wahab N; Abd El Hameed T Asian Pac J Cancer Prev; 2015; 16(17):7875-82. PubMed ID: 26625814 [TBL] [Abstract][Full Text] [Related]
25. Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study. Guièze R; Cornillet-Lefebvre P; Lioure B; Blanchet O; Pigneux A; Recher C; Bonmati C; Fegueux N; Bulabois CE; Bouscary D; Vey N; Delain M; Turlure P; Himberlin C; Harousseau JL; Dreyfus F; Béné MC; Ifrah N; Chevallier P; Am J Hematol; 2012 Dec; 87(12):1052-6. PubMed ID: 22911473 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934 [TBL] [Abstract][Full Text] [Related]
32. Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD. Ho AD; Schetelig J; Bochtler T; Schaich M; Schäfer-Eckart K; Hänel M; Rösler W; Einsele H; Kaufmann M; Serve H; Berdel WE; Stelljes M; Mayer J; Reichle A; Baldus CD; Schmitz N; Kramer M; Röllig C; Bornhäuser M; Thiede C; Ehninger G; Biol Blood Marrow Transplant; 2016 Mar; 22(3):462-9. PubMed ID: 26551637 [TBL] [Abstract][Full Text] [Related]
33. The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia. Aref S; Al Khodary T; Zeed TA; El Sadiek A; El Menshawy N; Al Ashery R Indian J Hematol Blood Transfus; 2015 Mar; 31(1):21-8. PubMed ID: 25548440 [TBL] [Abstract][Full Text] [Related]
34. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499 [TBL] [Abstract][Full Text] [Related]
35. Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia. Wu S; Dai Y; Zhang Y; Wang X; Wang L; Ma D; Zhang L; Pang Y; Jiao Y; Niu M; Xu K; Ke X; Shi J; Cheng Z; Fu L Cancer Gene Ther; 2018 Aug; 25(7-8):207-213. PubMed ID: 29904089 [TBL] [Abstract][Full Text] [Related]
36. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943 [TBL] [Abstract][Full Text] [Related]
37. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation? Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098 [TBL] [Abstract][Full Text] [Related]
38. [Clinical outcome of FLT3-ITD (+) acute myeloid leukemia patients treated with allogeneic hematopoietic stem cell transplantation]. Yang Z; Tian H; Xu Y; Qiu H; Chen S; Sun A; Wu D Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):94-8. PubMed ID: 24767158 [TBL] [Abstract][Full Text] [Related]
39. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885 [TBL] [Abstract][Full Text] [Related]
40. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia. Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]